PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
Bronchial Asthma
Anhui Palo Alto Pharmaceuticals, Inc.30 enrolled1 locationNCT07324707
Recruiting
Phase 2
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
Bronchial Asthma
Anhui Palo Alto Pharmaceuticals, Inc.60 enrolled1 locationNCT07326995